Results
|
1101.
|
|
|
1102.
|
|
|
1103.
|
Phase I immunotoxin trial in patients with B-cell lymphoma. [electronic resource] by
- Vitetta, E S
- Stone, M
- Amlot, P
- Fay, J
- May, R
- Till, M
- Newman, J
- Clark, P
- Collins, R
- Cunningham, D
Producer: 19910828
In:
Cancer research vol. 51
Availability: No items available.
|
|
1104.
|
|
|
1105.
|
|
|
1106.
|
|
|
1107.
|
|
|
1108.
|
|
|
1109.
|
|
|
1110.
|
|
|
1111.
|
|
|
1112.
|
Adduction of the human N-ras codon 61 sequence with (-)-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a] pyrene: structural refinement of the intercalated SRSR(61,2) (-)-(7S,8R,9S,10R)-N6-[10-(7,8,9,10- tetrahydrobenzo[a]pyrenyl)]-2'-deoxyadenosyl adduct from 1H NMR. [electronic resource] by Producer: 19960715
In:
Biochemistry vol. 35
Availability: No items available.
|
|
1113.
|
|
|
1114.
|
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. [electronic resource] by
- Amlot, P L
- Stone, M J
- Cunningham, D
- Fay, J
- Newman, J
- Collins, R
- May, R
- McCarthy, M
- Richardson, J
- Ghetie, V
Producer: 19931126
In:
Blood vol. 82
Availability: No items available.
|
|
1115.
|
|
|
1116.
|
|
|
1117.
|
|
|
1118.
|
|
|
1119.
|
|
|
1120.
|
|